Disulfiram-like reaction.
Should not be administered with disulfiram.
Source: G&G 14e · p1245-1266
Antidote · Substance dependence
Also known as Antabuse, Esperal
Disulfiram is an aldehyde dehydrogenase inhibitor. This inhibition leads to the accumulation of acetaldehyde, a toxic metabolite of alcohol, when alcohol is consumed. The resulting high concentrations of acetaldehyde cause unpleasant and potentially life-threatening symptoms, which discourages alcohol intake.
High concentrations of acetaldehyde which occur in presence of alcohol may be teratogenic; avoid in first trimester
Avoid—no information available
Disulfiram-like reaction.
Should not be administered with disulfiram.
Source: G&G 14e · p1245-1266
Psychotic reactions (acute confusional state, paranoid delusions) have occurred in patients taking metronidazole concurrently with disulfiram or within 14 days of disulfiram.
Do not administer metronidazole to patients who have taken disulfiram within the past 14 days. Wait at least 2 weeks after stopping disulfiram before starting metronidazole.
Source: Kimi deep-research + Cla
Psychotic reactions reported; both drugs affect alcohol metabolism
Do not use within 2 weeks of disulfiram
Source: Kimi deep-research + Cla
Increased barbiturate levels, potentially leading to increased CNS depression or toxicity.
Monitor for increased CNS depression. Dose adjustment of barbiturates may be necessary.
Source: G&G 14e · p528
Severe flushing, vomiting, hypotension, tachycardia
Intentional — patient must avoid all alcohol.
Drug interaction classified as: metabolism
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team